Direktorat Registrasi ObatValid

LAMIDO

Claim this product
BPOM Number
DKL2532724010A1
Approved
19 June 2025
Expiry
5 June 2030
Form
Tablet

About This Registration

LAMIDO is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL2532724010A1. Its current registration status is Valid, with the licence valid until 5 June 2030. The product is registered to YARINDO FARMATAMA and manufactured by YARINDO FARMATAMA - INDONESIA. BPOM first approved this registration in June 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 3 BLISTER @ 10 TABLET
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

LAMOTRIGINE

Market Intelligence

Owner Portfolio
YARINDO FARMATAMA holds 137 BPOM registrations
Manufacturer Scale
YARINDO FARMATAMA - INDONESIA produces 128 registered products
Registration Age
Registered for 1 year, 3 months

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from YARINDO FARMATAMA

GLUDEPATIC 500

-DKL2632724417A1
Valid
Approved: Apr 10, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717B1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717A1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

ARIPIPRAZOLE

-GKL2532723035A2
Valid
Approved: Dec 31, 2025CAIRAN ORAL
View product →

VERDON

-DKL2532723917A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
View product →

Products in the same class

MESOLA

-DKL1506316710A1
Valid
Approved: Jan 7, 2026TABLET
ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA
View product →

BISOPROLOL FUMARATE

-GKL2533516517C1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

FUROSEMIDE

-GKL2402368210A1
Valid
Approved: Dec 31, 2025TABLET
BERNOFARM - INDONESIA
View product →

VERDON

-DKL2532723917A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
YARINDO FARMATAMA
View product →

CEFIXIME TRIHYDRATE

-GKL1340701738A1
Valid
Approved: Dec 31, 2025SIRUP KERING
PHARMA LABORATORIES - INDONESIA
View product →
1